Noul Co., Ltd.

Noul is on a mission to empower resource-limited healthcare settings by providing a new, automated gold-standard blood cell diagnostics platform, MiLab. Noul is committed to overcoming limitations and challenging the status quo by integrating innovations in biochemistry, artificial intelligence, and engineering. Noul has filed over 65 global patents, conducted more than ten field clinical trials, and has research partnerships with world-class global institutions such as Harvard University, Columbia University, Swiss TPH, and FIND (Foundation for Innovative New Diagnostics) among others.